logo

For the Inventor, By the Inventor

Horsham, United Kingdom

Bernard Cuenoud

This inventor holds 18 USPTO granted patents, plus 1 CIPO patent, primarily in Beta-2 Agonists. Top assignee: Novartis Ag. Active years: 2003-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernard Cuenoud. Retrieved from https://idiyas.com/inventor/bernard-cuenoud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18

% Patents Active = 38.9


Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 170(Granted Patents)


Location History:

  • Basel, CH (2011)
  • Lausanne, CH (2004 - 2013)
  • Horsham, GB (2003 - 2015)

Company Filing History:

goldMedal18 out of 3,978 
 
Novartis Ag
 patents

Years Active: 2003-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Beta-2 Agonists
Phosphatidylinositol 3-Kinase
Airway Diseases
Quinoline Derivatives
Organic Compounds
Nucleosides
Formoterol
Tiotropium
Inhibitors
Mixtures
Phenylthiazole
18 patents (USPTO):Explore Patents
1. 9040559 - BETA2-adrenoceptor agonists (2015-05-26),
2. 8796307 - Beta2-adrenoreceptor agonists (2014-08-05),
3. 8658673 - BETA2-adrenoreceptor agonists (2014-02-25),
4. 8436017 - Beta-2-adrenoreceptor agonists (2013-05-07),
5. 8404684 - Inhibitors of phosphatidylinositol 3-kinase (2013-03-26),
6. 8283362 - Beta-2-adrenoreceptor agonists (2012-10-09),
7. 8067437 - Beta-2-adrenoreceptor agonists (2011-11-29),
8. 8017608 - 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors (2011-09-13),
9. 7820694 - Beta-2-adrenoreceptor agonists (2010-10-26),
10. 7745462 - Quinoline-2-one derivatives for the treatment of airways diseases (2010-06-29),
11. 7622484 - Mixtures or organic compounds for the treatment of airway diseases (2009-11-24),
12. 7622483 - β2-adrenoceptor agonists (2009-11-24),
13. 7008951 - Mixtures or organic compounds for the treatment of airway diseases (2006-03-07),
14. 6921757 - Organic compounds (2005-07-26),
15. 6878721 - Beta2-adrenoceptor agonists (2005-04-12),

Title: The Innovative Contributions of Bernard Cuenoud

Introduction

Bernard Cuenoud is a prominent inventor based in Horsham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating obstructive or inflammatory airways diseases. With a total of 18 patents to his name, Cuenoud's work has had a substantial impact on medical science.

Latest Patents

Cuenoud's latest patents include innovative compounds known as BETA2-adrenoceptor agonists. These compounds are described in detail as having a specific formula in free, salt, or solvate form. The compounds are designed for use as pharmaceuticals, particularly targeting obstructive or inflammatory airways diseases. His work in this area showcases his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Throughout his career, Bernard Cuenoud has been associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovation.

Collaborations

Cuenoud has worked alongside notable colleagues such as Robin Alec Fairhurst and Ian Bruce. These collaborations have played a crucial role in the development of his patented inventions and have fostered a productive environment for innovation.

Conclusion

Bernard Cuenoud's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through numerous patents and collaborations highlight his dedication to improving healthcare solutions. His ongoing efforts continue to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…